FDA says 4 million N95 masks could be reused

Emergency-use authorizations allow sterilizing and reprocessing N95 masks


The FDA has issued emergency-use authorizations (EUA) for sterilizing and reprocessing N95 masks, according to an article on the HCPro website.

Approximately 4 million N95 or N95-equivalent respirators can be decontaminated per day in the U.S. for reuse by healthcare workers in hospital settings, according to the agency.

N95 masks are placed in a room, sprayed with vaporized hydrogen peroxide using a special machine and left to dry. 

A mask can be reprocessed up to 10 times for single-user reuse. 

Read the article.

 



April 27, 2020


Topic Area: Infection Control


Recent Posts

Inside Good Shepherd Rehabilitation Hospital's Modern Transformation

The newly transformed facility was designed to incorporate materials and spaces to benefit patient healing.


Report Sheds Light on Cyberattack and Data Breach Trends from 2024

Despite a slight decrease in data breaches from 2023, the volume of exposed data and records surged.


Hampstead Hospital Officially Joins Dartmouth Health

This will make Dartmouth solely responsible for the clinical leadership, patient care and operation of Hampstead Hospital and Residential Treatment Facility.


HCA Florida Healthcare Announces Plans for Three New Freestanding ERs

Construction is expected to begin on the three facilities in 2025, with completion anticipated in 2026.


Barriers to Infection: Rethinking Mattress Cleaning

Laundering removable bed barriers provides a more effective, consistent and safer method for eliminating harmful bacteria compared to manual cleaning.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.